NCT01692652
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- department of Ophthalmology, Yonsei University College of Medicine Seoul, South Korea
Clinical trial condition
Moderate and Severe Meibomiang Gland Dysfunction (Stage 3 or Stage 4 Meibomiang Gland Dysfunction)
Explore clinical trials studying Moderate and Severe Meibomiang Gland Dysfunction (Stage 3 or Stage 4 Meibomiang Gland Dysfunction). Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies